Athena Pelvic Muscle Trainer - DUETS Trial

NCT ID: NCT01073878

Last Updated: 2011-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

462 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if the Athena Pelvic Muscle Trainer device effectively treats stress, urge or mixed incontinence in women by strengthening the pelvic floor muscles by collecting data from the patient on the

1. Over Active Bladder Questionnaire
2. The 7-Day Urine Diary questionnaire

This study will also look at whether or not there is an improvement in sexual health after using the device by collecting data frm the patient on the
3. Female Sexual Function Index questionnaire

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a Phase IV, prospective, open-label, multi-center, observational study to assess the effectiveness of the Athena PMT to relieve or eliminate the symptoms of female urinary incontinence.

The study will enlist approximately 100 or more Nurse-Practitioners in Women's Health as the principle investigators from community-based primary care centers (OB-GYN, Internal Medicine, Family Practices or Women's Health Centers) who will enroll approximately 500 or more subjects who suffer from urge and/or stress urinary incontinence and who may benefit from strengthening of Kegel muscles of the pelvic floor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Athena Pelvic Muscle Trainer

The Athena PMT is a vaginally inserted electrical stimulator that induces the pelvic floor muscles to contract and relax, similar to Kegel exercises intended to strengthen the pelvic floor muscles.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Athena PMT PMT Pelvic Muscle Trainer Athena

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women between the ages of 30 and 70 years
2. Suffer from urge-incontinence, stress incontinence or incontinence of mixed etiology and who may benefit from strengthening Kegel muscles by electrical stimulation
3. Able to provide informed consent and physically able to comply with protocol requirements.
4. Experience one or more incontinence episodes per week.
5. Women of childbearing potential must have a negative urine or blood pregnancy test within 7 days prior to initiation of treatment.
6. Subject may be post-menopausal, surgically sterilized, or willing to use acceptable methods of birth control (e.g., hormonal contraceptive, intra- uterine device (IUD), diaphragm with spermicide, condom with spermicide or abstinence) from the screening visit through the duration of study participation.
7. Have a positive response to two or more questions on the Athena Questionnaire

Exclusion Criteria

1. Neurological deficiency that does not permit proper sensory perception or stimulation.
2. Is currently pregnant, lactating or attempting to get pregnant
3. Has a cardiac pacemaker or a history of rate or conductive disturbance
4. Has anatomical vaginal structures that do not permit proper and complete placement of the trainer.
5. Has irregular menstrual bleeding cycles.
6. Has urinary or vaginal infections, localized lesions, or other undiagnosed symptoms.
7. Has a history or symptoms of urinary retention.
8. Has cancer or a life expectancy of less than one year
9. Recreational drug use
10. Consume more than three caffeine beverages daily
11. Consume more than 1-2 alcoholic drinks per day
12. Significant drug use (causing diuresis or urinary retention
13. Allergy or sensitivity to materials in the Athena PMT
14. Participation in another clinical trial within past 3 months
15. Subjects morbidly obese (BMI \>35)
16. Subjects who chronically smoke (\> 10 cigarettes per day)
17. Subjects required to do heavy lifting (\> 40 pounds regularly)
18. Surgery within the past six months for incontinence, or use of other incontinence devices
19. Currently taking cholinergic or anti-cholinergic drugs or other prescription or non-prescription drugs that may increase or decrease the volume or frequency of urination and thus, may confound the results of this study, except, in the opinion of the investigator. The subject's regimen has been stable for at least sixty days.
20. Suspected infection or condition (e.g., diabetes) that would alter the subjects ability to participate or would confound the results of the trial
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Athena Feminine Technologies, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Athena FT

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julia Shaw, MD

Role: STUDY_DIRECTOR

Director of Women's Health, Yale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

John Foster MD

Birmingham, Alabama, United States

Site Status

La Mamma Spa

Birmingham, Alabama, United States

Site Status

Kyle Chavers MD

Dothan, Alabama, United States

Site Status

Salud! for Women

Casa Grande, Arizona, United States

Site Status

New Horizons Women's Care

Chandler, Arizona, United States

Site Status

Barbara Wiggin PhD, ANP-C

Peoria, Arizona, United States

Site Status

Agnes Oblas APRN

Phoenix, Arizona, United States

Site Status

Arcadia Well Woman

Scottsdale, Arizona, United States

Site Status

Patricia A Faust

Tempe, Arizona, United States

Site Status

Beth Andresen

Tucson, Arizona, United States

Site Status

Teresa Mote RNC NP

Tucson, Arizona, United States

Site Status

Brenda Hanson-Smith, RN, DNS, OGNP

El Dorado Hills, California, United States

Site Status

Lynda Reed

Ontario, California, United States

Site Status

Rose Mary Mosher

Rolling Hills Est., California, United States

Site Status

Evan Vapnek MD

San Diego, California, United States

Site Status

Marilyn Brooks

San Jacinto, California, United States

Site Status

Healthworks

San Luis Obispo, California, United States

Site Status

Maureen Allen

Northglenn, Colorado, United States

Site Status

Kristan Langdon, ANP-C

Parker, Colorado, United States

Site Status

Karen D. Adamson

Salida, Colorado, United States

Site Status

Merrilyn H. McNatt APRN

New London, Connecticut, United States

Site Status

Jean Ohliger APRN

South Windsor, Connecticut, United States

Site Status

Arlena Falcon

Blountstown, Florida, United States

Site Status

Carl Spirazza

Boynton Beach, Florida, United States

Site Status

Khadra Mohamoud Osman mD

Fort Lauderdale, Florida, United States

Site Status

Shelly E Kramer ARNP

Lake Worth, Florida, United States

Site Status

Ivonne M. Reynolds

Margate, Florida, United States

Site Status

Susan Chappuis, ARNP-C

Ormond Beach, Florida, United States

Site Status

Elizabeth Tsarnas

Stuart, Florida, United States

Site Status

Bayside Gynecology, P.A.

Venice, Florida, United States

Site Status

Jeffrey C Seiler, MD

West Palm Beach, Florida, United States

Site Status

Deborah Cothran WHNP-BC

Albany, Georgia, United States

Site Status

Elizabeth Killebrew MD

Fayetteville, Georgia, United States

Site Status

Michael D Benson

Deerfield, Illinois, United States

Site Status

Laurie Knoke

DeKalb, Illinois, United States

Site Status

Sherry Owen, APN

Gurnee, Illinois, United States

Site Status

Julie Snow

Park Ridge, Illinois, United States

Site Status

Kathryn A. Copeland

Carmel, Indiana, United States

Site Status

Matthew Sprunger MD

Fort Wayne, Indiana, United States

Site Status

Tamara Meisel ARNP

Lakin, Kansas, United States

Site Status

Richard F. Ford MD

Ashland, Kentucky, United States

Site Status

Women's Care Center

Lexington, Kentucky, United States

Site Status

Tammi K Herkey

Bossier City, Louisiana, United States

Site Status

Stefanie A Schultis

Covington, Louisiana, United States

Site Status

Steven Lenowitz, MD

Bel Air, Maryland, United States

Site Status

Kathryn Cervi

Columbia, Maryland, United States

Site Status

Elizabeth P Sipala

Galena, Maryland, United States

Site Status

Deborah A. Davis, MSN, CRNP

Prince Frederick, Maryland, United States

Site Status

Martha Klay

Great Barrington, Massachusetts, United States

Site Status

Pioneer Valley Urology

Springfield, Massachusetts, United States

Site Status

Margaret Duggan

Walpole, Massachusetts, United States

Site Status

Kathryn Koches

Dearborn, Michigan, United States

Site Status

Women's Health Care Specialists, PC

Paw Paw, Michigan, United States

Site Status

Isabel M Raposo

Riverview, Michigan, United States

Site Status

Laura Hintz

Saginaw, Michigan, United States

Site Status

Mickie G. Autry PhD, NP-C

Jackson, Mississippi, United States

Site Status

Kathleen M. Young RNC NP

Kalispell, Montana, United States

Site Status

Urogynecology Arts of New Jersey

East Brunswick, New Jersey, United States

Site Status

Lynda M. Adamson

Galloway, New Jersey, United States

Site Status

Women's Total Health

Hamburg, New Jersey, United States

Site Status

Cindy Nevara APN

Vineland, New Jersey, United States

Site Status

Jeanne Ann Dahl, RNC, WHNP

Albany, New York, United States

Site Status

Meredith Schledorn

Cortland, New York, United States

Site Status

Raj Mahajan MD

Oswego, New York, United States

Site Status

Diane Stonemetz

West Seneca, New York, United States

Site Status

Kathy Edwards

Minot, North Dakota, United States

Site Status

Columbus OB/Gyn Inc.

Columbus, Ohio, United States

Site Status

Holly Murphy

Columbus, Ohio, United States

Site Status

Susan Frost

Columbus, Ohio, United States

Site Status

Amy G Brenner M.D

Fairfield, Ohio, United States

Site Status

Elizabeth D. Allen CNP

Gallipolis, Ohio, United States

Site Status

William Shuler, MD

Tulsa, Oklahoma, United States

Site Status

Deborah Malone

Bend, Oregon, United States

Site Status

Anne Marie Moore, Womens Health Nurse Practitioner

Eugene, Oregon, United States

Site Status

Cathleen Ann Folk FNP

Portland, Oregon, United States

Site Status

Mary L Hagood, FNP-C

Roseburg, Oregon, United States

Site Status

Institute for Female Pelvic Medicine

Allentown, Pennsylvania, United States

Site Status

Paulette Schreiber, CRNP

Saint Mary's, Pennsylvania, United States

Site Status

Marie T Ziegler

West Chester, Pennsylvania, United States

Site Status

Nancy Newman RNC, WHNP

Lexington, South Carolina, United States

Site Status

Sharon Little

Collierville, Tennessee, United States

Site Status

Margaret A. Hull

Franklin, Tennessee, United States

Site Status

Urology Associates, P.C.

Nashville, Tennessee, United States

Site Status

John Pickel MD

Arlington, Texas, United States

Site Status

Christopher J. Jayne, MD, FACOG

Houston, Texas, United States

Site Status

Urology San Antonio

San Antonio, Texas, United States

Site Status

Marney Kidwell RNC

San Antonio, Texas, United States

Site Status

D. Crawford Allison MD

Waco, Texas, United States

Site Status

Laura C. Maw

Lehi, Utah, United States

Site Status

Betsy Browning

Bennington, Vermont, United States

Site Status

Anne L Stephens

Chesapeake, Virginia, United States

Site Status

Rand Gynecology, LLC

Chesapeake, Virginia, United States

Site Status

Julie Spencer

Lansdowne, Virginia, United States

Site Status

Patrice C Malena

Newport News, Virginia, United States

Site Status

Ocean Beach Women's Clinic

Ilwaco, Washington, United States

Site Status

Kimberly Scheer

Vashon, Washington, United States

Site Status

Primary Care, PLLC

Christiansted, VI, Virgin Islands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Virgin Islands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PMT-4-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.